AI Biomed PredictionsBRTX – Depressed BRTX Awaits Its Next Real Clinical Repricing Trigger ScanScor Admin / April 27, 2026
AI Biomed PredictionsOTLK – May FDA dispute ruling could decide OTLK’s next surge ScanScor Admin / April 26, 2026
AI Biomed PredictionsOTLK – May FDA dispute ruling could decide OTLK’s next surge ScanScor Admin / April 26, 2026
AI Biomed PredictionsQTTB – Q32 Bio Faces Its Defining Mid-2026 Alopecia Data Test ScanScor Admin / April 21, 2026
AI Biomed PredictionsCING – May FDA decision could redefine Cingulate’s tiny-cap valuation ScanScor Admin / April 18, 2026
AI Biomed PredictionsCVKD – Phase 3 clarity could revive battered microcap HIT story ScanScor Admin / April 17, 2026
AI Biomed PredictionsMBRX – Mid-2026 AML unblinding could redefine tiny-cap MBRX valuation ScanScor Admin / April 16, 2026
AI Biomed PredictionsNRXP – Summer FDA Ketamine Decision Could Reawaken NRXP Speculation ScanScor Admin / April 13, 2026
AI Biomed PredictionsBIVI – BioVie’s next real test is the mid-2026 Parkinson’s readout ScanScor Admin / April 12, 2026
AI Biomed PredictionsCNTB – Midyear Seabreeze data could decide CNTB’s next breakout ScanScor Admin / April 12, 2026
